The biosimilars market is a rapidly growing sector in the pharmaceutical industry. Biosimilars are highly similar versions of biologic drugs that have already been approved by regulatory authorities. These drugs are developed to be highly similar in terms of safety, efficacy, and quality to their reference products.
One of the key drivers behind the growth of the biosimilars market is the increasing demand for cost-effective treatment options. Biologic drugs are known for their high costs, making them inaccessible to many patients. Biosimilars offer a more affordable alternative, providing patients with access to life-saving treatments at a lower price point.